Skip to main content

Quarter of UK University Physics Departments At Risk of Closing, Survey Finds

2 months 3 weeks ago
An anonymous reader quotes a report from The Guardian: The heads of UK physics departments say their subject is facing a national crisis as one in four warns that their university departments are in danger of closing because of funding pressures. In an anonymous survey of department heads by the Institute of Physics (IoP), 26% said they faced potential closure of their department within the next two years, while 60% said they expected courses to be reduced. Four out of five departments said they were making staff cuts, and many were considering mergers or consolidation in what senior physicists described as a severe threat to the UK's future success. [...] To avoid "irreversible damage", the IoP is asking for immediate government action including funding to support existing labs and research facilities, as well as setting up an "early warning system" to monitor departments at risk of closure, and reduce pressures affecting international student recruitment. In the longer term it is calling for radical reforms in higher education funding to allow universities to meet the full costs of teaching nationally important subjects such as physics. Sir Keith Burnett, the IoP's president and a former chair of physics at Oxford University, said: "While we understand the pressures on public finances, it would be negligent not to sound the alarm for a national capability fundamental to our wellbeing, competitiveness and the defense of the realm. "We are walking towards a cliff edge but there is still time to avert a crisis which would lead not just to lost potential but to many physics departments shutting down altogether. Physics researchers and talented physics students are our future but if action isn't taken now to stabilize, strengthen and sustain one of our greatest national assets, we risk leaving them high and dry." Thomas said the erosion in value of domestic tuition fees and falling numbers of international students were behind the financial pressures, with smaller physics departments the most at risk. "What that means is we will get more and more concentration of where physics is being taught and lose geographical distribution. That goes against aims of widening participation and means some disadvantaged groups will miss out on opportunities to study physics, and it's important that we recognize that," Thomas said.

Read more of this story at Slashdot.

BeauHD

CBS News Was Just Taken Over By a Substack

2 months 3 weeks ago
Paramount has acquired The Free Press, Bari Weiss's Substack-born media outlet, for $150 million and appointed Weiss as editor-in-chief of CBS News. The move effectively places a conservative-leaning Substack writer at the helm of a legacy news network, following the FCC's approval of the Skydance-Paramount merger, which required CBS to feature a broader "diversity of viewpoints from across the political and ideological spectrum." The Verge reports: Before starting The Free Press, Weiss worked as an op-ed and book review editor at The Wall Street Journal from 2013 to 2017 and later became an op-ed editor and writer at The New York Times to expand the publication's stable of conservative columnists during Donald Trump's first term. She resigned from the NYT in 2020, citing an "illiberal environment." Weiss started a Substack newsletter in 2021, called Common Sense, which later evolved into The Free Press, touting itself as a media company "built on the ideals that were once the bedrock of great American journalism." As noted in the press release, The Free Press has grown its revenue 82 percent over the past year, while subscribers increased 86 percent to 1.5 million, 170,000 of which are paid subscriptions.

Read more of this story at Slashdot.

BeauHD

AstraZeneca Signs Up For $555 Million AI Deal With Algen To Develop Therapies

2 months 3 weeks ago
AstraZeneca has licensed Algen Biotechnologies' AI-powered gene-editing platform, AlgenBrain, to develop immune-related therapies in a deal worth up to $555 million. Reuters reports: AstraZeneca will get exclusive rights to develop and sell approved therapies, if any, that target immune system-related disorders in exchange for upfront and milestone payments to Algen. AstraZeneca has been advancing its cell and gene therapy capabilities through acquisitions and partnerships as it works towards its target of $80 billion in sales by 2030. Globally too, drugmakers are increasingly turning to artificial intelligence for drug development. Monday's deal, however, does not include AstraZeneca buying a stake in the company, Algen CEO and co-founder Chun-Hao Huang told Reuters in an interview. "Together with AstraZeneca's deep expertise in translational science and clinical development, we aim to uncover new biological insights to accelerate the development of novel therapies," Huang said. Algen was spun out from the UC Berkeley lab where biochemist Jennifer Doudna pioneered the CRISPR technology that won her the Nobel Prize. The biotech firm's AI platform, AlgenBrain, can map genes to disease outcomes, helping the companies decide their development focus for targeted therapies.

Read more of this story at Slashdot.

BeauHD